The interest comes amid growing use of GLP-1 drugs such as Wegovy and Mounjaro. Companies including Givaudan, IFF and L'Oréal are investigating whether changes in eating habits and sensory experiences could also influence consumers' perfume preferences.
This was reported by Reuters, which has explored how weight-loss drugs are affecting people's lives in ways that go far beyond their weight in a series of articles.